HIMS
Value In WatchlistHims Hers Health Inc
Company Overview
hims.comHims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...nd wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Fundamental Snapshot
Company Info
Valuation
Profitability
Risk / Health
Interpretation:
8-9: Very Strong
5-7: Stable
0-4: Weak (Risk)
Interpretation:
> 3.0: Safe Zone
1.8 - 3.0: Grey Zone
< 1.8: Distress Zone (High Risk)
Interpretation:
< -1.78: Unlikely Manipulator
> -1.78: Possible Manipulator
Price (1Y)
Revenue Growth (YoY)
28.4%
Revenue CAGR (3Y)
60.5%
Revenue CAGR (5Y)
70.7%
Earnings CAGR (3Y)
-5.7%
FCF CAGR (3Y)
196.0%
FCF CAGR (5Y)
117.5%
Industry Benchmark: Drugs (Pharmaceutical)
228 firms | Source: DamodaranPE (Current)
335.3x
PE (Forward)
24.2x
P/S
5.63x
EV/EBITDA
15.2x
ROE
24.0%
Net Margin
18.5%
Income & Cash Flow
Revenue ($B)
Gross Profit ($B)
Operating Income ($B)
Net Income ($B)
Free Cash Flow ($B)
Op. Cash Flow ($B)
Expenses
Cost of Revenue ($B)
Operating Expenses ($B)
R&D Expense ($B)
SG&A Expense ($B)
Cash & Debt
Cash & Equivalents ($B)
Total Debt ($B)
Net Debt ($B)
Shareholders' Equity ($B)
Shares, Dividends & Valuation
Shares Outstanding (B)
Dividends Paid ($B)
P/E Ratio
P/S Ratio
EV/EBITDA
Price vs FCF Fair Value
Avg: 36.8xPrice vs OCF Fair Value
Avg: 47.5xPrice vs Earnings Fair Value
Avg: 80.5xPrice vs EBIT Fair Value
Avg: 160.3xPrice vs EBITDA Fair Value
Avg: 125.7xPrice vs Sales Fair Value
Avg: 4.7xSegment KPIs
Coming soon - custom metrics from company filings